Updated Jul 16, 2026
Connealy Pamela Ann has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $174K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-25 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 17.3K | $0.00 | |
| 2025-08-07 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 15.0K | $0.00 | |
| 2024-11-27 | PYXS | Pyxis Oncology, Inc. | P — Open-market purchase | 83.4K | $1.96 | $163K |
| 2024-11-27 | PYXS | Pyxis Oncology, Inc. | P — Open-market purchase | 5.5K | $2.00 | $11K |
Connealy Pamela Ann is a corporate insider — currently tracked as Director of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($174K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Connealy Pamela Ann profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.